Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
2.000
0.00 (0.00%)
At close: Dec 31, 2025, 4:00 PM EST
2.050
+0.050 (2.50%)
Pre-market: Jan 2, 2026, 7:33 AM EST
Microbot Medical Stock Forecast
Stock Price Forecast
The 2 analysts that cover Microbot Medical stock have a consensus rating of "Strong Buy" and an average price target of $8.75, which forecasts a 337.50% increase in the stock price over the next year. The lowest target is $5.50 and the highest is $12.
Price Target: $8.75 (+337.50%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 3, 2025.
Analyst Ratings
The average analyst rating for Microbot Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth Capital | Roth Capital | Strong Buy Initiates $5.5 | Strong Buy | Initiates | $5.5 | +175.00% | Dec 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +500.00% | Nov 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +500.00% | Oct 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +500.00% | Sep 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +350.00% | Apr 10, 2025 |
Financial Forecast
Revenue This Year
153.00K
Revenue Next Year
4.93M
from 153.00K
Increased by 3,119.61%
EPS This Year
-0.31
from -0.73
EPS Next Year
-0.35
from -0.31
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 315,000 | 7.1M | |
| Avg | 153,000 | 4.9M | |
| Low | n/a | 2.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 4,566.7% | |
| Avg | - | 3,119.6% | |
| Low | - | 1,730.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.32 | -0.35 | |
| Avg | -0.31 | -0.35 | |
| Low | -0.30 | -0.34 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.